December 7-8, 2026
Hilton La Jolla Torrey PinesLa Jolla, CAAlign Medicaid, Commercial & Government Teams to Deliver Market-Leading Results
Unite with best-in-class industry leaders from established and emerging pharma/bio manufacturers, government regulators and additional stakeholders to tackle the complex regulatory and operational challenges related to IRA, MFN, MFP, 340B, Medicaid, State Drug Price Transparency and more!
Experience all the latest in pricing and contracting for life sciences
With insights gained from our vibrant pricing and contracting community, we're primed for another ground-breaking event - this time we're HEADED WEST! Whether you're a seasoned pro or a newcomer, get ready for an upgraded program packed with cutting-edge topics such as Medicaid, Government Pricing and Policy, Drug Price Transparency, 340B, IRA, MFN, MFP and more.
Don't just take our word for it — check out the thrilling preview of what's to come in 2026 in La Jolla, California!
Navigate the Complex Policy Landscape with Expert-Led Insights
- Hear from CMS and PhRMA leadership on the latest updates for IRA, MFN developments, 340B expansion, and PBM reform.
- Learn operational strategies for MFN/MFP preparation, state transparency requirements, and ASP calculation challenges through practical case studies and panel discussions.
- Discover how leading organizations align government pricing, commercial contracting, finance, and legal teams to navigate AMP, Best Price, and GTN relationships.
Master Complex Market Challenges
- Explore outcomes-based agreements, innovative contracting models, and government pricing implications for Cell & Gene therapy products.
- Learn practical approaches to mitigate 340B & duplicate discount risk, revenue leakage and strategize on innovative rebate model programs.
- Understand how pioneering strategies for GTN optimization impact long-term profitability.
Connect, Collaborate & Transform Your Network
- Join senior-leadership closed-door discussions on 340B reform, MFN/MFP readiness, Medicaid disputes, and AI adoption.
- Hear from current and former State Medicaid Directors sharing operational realities and priorities shaping program decision-making.
- Maximize connections through dedicated breaks, luncheons and a reception with government pricing executives, market access leaders, and policy experts.
